a global survey of pharmaceutical industry leaders that have adopted or consider adopting low-code/no-code
Strategic insights for digital & IT leaders
on how organizations that have adopted or considering adopting low-code/no-code unlock digital transformation success
Download the researchKEY HIGHLIGHTS
of pharma industry leaders plan to continue their ongoing transformation
of respondents say that low-code/no-code is faster than traditional development
knowledge workers are looking for a way to automate their processes
Low-code/no-code is adopted primarily for accelerated time to market and reduced app development cost
Low-code/no-code technology is key enabler of digital transformation in the pharma industry
Low-code/no-code is adopted primarily for accelerated time to market and reduced app development cost
Low-code/no-code technology is key enabler of digital transformation in the pharma industry
CEO at Valoir, CRM expert
As Creatio’s research shows, companies are seeking to continue or accelerate digital transformation and automation in 2021. Beyond escaping the initial IT constraints, low-code/no-code technologies enable them to put tools in the hands of the business users who are best able to identify and enable process improvements and innovations, and continue to adapt them over time.
I applaud Creatio’s efforts to be a thought leader in the low-code/no-code space. This research highlights the company’s understanding of the innovations and challenges in the low-code/no-code space as well as its long history of providing no-code/low-code capabilities to business users around the world.
Download your complimentary copy of the global market research to get strategic insights
Download the researchDownload the research
From December 2020 to January 2021, Creatio surveyed senior level decision makers in the pharmaceutical industry from varying geographies to gain an inside look at the goals and challenges of digital transformation and process automation.
Read about how ready organizations are to adopt low-code/no-code technologies as part of their transformation strategy and why.
DIGITAL TRANSFROMATION IN THE PHARMACEUTICAL INDUSTRY
- The driving forces behind the digital transformation: introducing new products and services at neck-breaking speed
- Key barriers to accelerating digital transformation
- How the increased demand for products shapes the pharmaceutical industry after COVID-19
WINNING WITH LOW-CODE/NO-CODE
- How pharma industry leaders enable process automation with no-code/low-code tools
- New ways of meeting businesses’ needs and supporting customers in unprecedented times
- Technology trends for pharma: machine learning, AI and big data analytics
ENABLING ACCELERATION WITH LOW-CODE/NO-CODE TOOLS
- An increased focus on digital innovation and customer-facing apps
- Digitizing the companies’ core capabilities to influence an organization’s bottom line and KPIs
- How low-code/no-code development approach helps organizations automate their workflows with fewer resources and at light speed
THE FUTURE OUTLOOK
- How remote work and anywhere operations will continue to impact pharma businesses
- An increased influence of new technologies on the patients’ health journeys
- A new culture of citizen development: why every successful organization is now a software company
To find out more about digital transformation trends
and the future of low-code/no-code
Download the researchDownload the research
